Look for:

Products

CUREVAC NV


ISIN:
NL0015436031
WKN:
N2451R105

2024/07/17 17:44:59
Price
3.174 EUR
Difference 0.00% (0.00)

General attributes

ISINNL0015436031
SymbolCVAC
ExchangeEuronext Milan MTF Global Equity Market
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)748 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)3.206 EUR (1,500)
Ask (Ask size)3.436 EUR (1,500)
Open3.272 EUR
High3.272 EUR
Low3.272 EUR
Close (prev. day)3.174 EUR
VWAP3.272 EUR
Volume (pcs)450
Trading volume1,472.00
Number of trades1
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: CUREVAC NVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/07/17 17:44:59
Price
3.174 EUR
Difference 0.00% (0.00)

General attributes

ISINNL0015436031
SymbolCVAC
ExchangeEuronext Milan MTF Global Equity Market
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)748 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)3.206 EUR (1,500)
Ask (Ask size)3.436 EUR (1,500)
Open3.272 EUR
High3.272 EUR
Low3.272 EUR
Close (prev. day)3.174 EUR
VWAP3.272 EUR
Volume (pcs)450
Trading volume1,472.00
Number of trades1
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-6.09%--
Perf (abs.)-0.21--
Beta0.840.850.90
Volatility75.30--
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)3.083 EUR (2,856)
Ø price 30 days | Ø volume 30 days (pcs.)3.300 EUR (2,605)
Ø price 100 days | Ø volume 100 days (pcs.)3.049 EUR (2,042)
Ø price 250 days | Ø volume 250 days (pcs.)- EUR (-)
YTD High | date4.698 EUR (2024/06/07)
YTD Low | date2.128 EUR (2024/04/25)
52 Weeks High | date- EUR (-)
52 Weeks Low | date- EUR (-)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/07/1810:143.354 EUR0.0264
Vienna Stock Exchange2024/07/1717:323.168 EUR0.005
Tradegate2024/07/1810:163.328 EUR0.1043
Stuttgart2024/07/1810:053.328 EUR0.017
Nasdaq2024/07/1722:003.65 USD3.678,778
Munich2024/07/1808:073.302 EUR0.001
London Stock Exchange European Trade Reporting2024/07/1810:003.635 USD0.001
Hanover2024/07/1808:003.296 EUR0.001
Hamburg2024/07/1808:003.296 EUR0.001
Frankfurt2024/07/1810:143.314 EUR0.015
Euronext Milan MTF Trading After Hours2024/07/1717:443.174 EUR0.001
Euronext Milan MTF Global Equity Market2024/07/1717:443.174 EUR0.001
Duesseldorf2024/07/1809:303.312 EUR0.002
Berlin2024/07/1808:083.292 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=146151&ID_TYPE_IMAGE_LOGO=2

Contact Details

CUREVAC NV
- -
Friedrich-Miescher-Strasse 15 - 72076 Tübingen
Telefon: +49-7071-9883-0
Fax: +49-7071-9883-1101
E-mail: info@curevac.com

PDF Downloads

Company report: CUREVAC NVPDF Download

Company Profile

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.

Members of Management Board

Alexander ZehnderChairman of Managing Board
Malte GreuneMember of Executive Committee
Myriam MendilaMember of Executive Committee
Pierre KemulaMember of Executive Committee
Thaminda RamanayakeMember of Executive Committee

Board of directors

Baron Jean StéphenneChairman of Supervisory Board
Debra Stephanie BarkerMember of Supervisory Board
Klaus SchollmeierMember of Supervisory Board
Mathias HothumMember of Supervisory Board
Viola BronsemaMember of Supervisory Board
Birgit HofmannMember of Supervisory Board
Craig ToomanMember of Supervisory Board
Michael BrosnanMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.